Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Drug Target in Rare, Lethal Glandular Cancer Discovered

April 19, 2016 3:21 pm | by Yale University | News | Comments

New data shows that ACC and similar cancers could be treated with already available drugs.

TOPICS:

Scientists Propose Treatment for Severe Lung Diseases

April 19, 2016 3:14 pm | by Cincinnati Children's Hospital Medical Center | News | Comments

Researchers are following up their current study with further development of the targeted small molecule they recently discovered.

TOPICS:

UnitedHealth Ups 2016 Outlook after Surprisingly Strong 1Q

April 19, 2016 2:44 pm | by Tom Murphy, AP Business Writer | News | Comments

UnitedHealth hiked its 2016 forecast after the nation's largest health insurer topped Wall Street's first-quarter earnings expectations.

TOPICS:
Advertisement

Research Opens Door for Monocyte-Based Cell Therapy

April 19, 2016 2:41 pm | by VIB | News | Comments

Using a mouse model for pulmonary alveolar proteinosis, the authors demonstrate that this rare disease can be cured by a single transfer of monocytes.

TOPICS:

Pfizer Announces Positive Top Line Results for Phase 3 Ibrance Study

April 19, 2016 1:55 pm | News | Comments

Since its introduction in February 2015, more than 25,000 women have been prescribed IBRANCE by more than 6,000 prescribers in the U.S.

TOPICS:

Study Provides Structural Basis for Development of New Antibiotic

April 19, 2016 12:37 pm | by Duke University | News | Comments

Antibiotic-resistant infections are a growing threat to public health.

Molecular Zika Study Finds Possible Target for Tests, Drugs

April 19, 2016 12:32 pm | by University of Minnesota | News | Comments

Identifying NS1 also helps to diagnose infections, and other research teams are eyeing it as a possible target for antiviral drug development.

TOPICS:

Precision Prevention of Colorectal Cancer

April 19, 2016 10:15 am | by Fred Hutchinson Cancer Research Center | News | Comments

Precision medicine's public face is that of disease -- and better treatments for that disease through targeted therapies. But precision medicine has an unsung partner that could affect the lives of many more people: Precision prevention.

TOPICS:
Advertisement

Study Backs Pancreas Cell Transplants for Severe Diabetes

April 19, 2016 9:52 am | by Lauren Neergaard, AP Medical Writer | News | Comments

Transplants of insulin-producing pancreas cells are a long hoped-for treatment for diabetes - and a new study shows they can protect the most seriously ill patients from a life-threatening complication of the disease, an important step toward U.S. approval.

TOPICS:

How Purdue Pharma Helped Spark the Opioid Epidemic

April 19, 2016 9:12 am | by Richard Gunderman, The Conversation | News | Comments

The sources of the opioid epidemic are complex, but one powerful motivator has been the pursuit of profit. 

TOPICS:

Hormone Drug Could Cure Asthma, Other Fibrosis-Related Diseases

April 19, 2016 9:00 am | by Monash University | News | Comments

Key to this process is Relaxin’s ability to break down collagen.

TOPICS:

Xanthohumol Lowers Cholesterol, Blood Sugar, and Weight Gain

April 19, 2016 8:56 am | by Oregon State University | News | Comments

More research will be required to show safety and efficacy in humans.

TOPICS:

Double Advantage of Potential New Diabetes Treatment

April 19, 2016 8:51 am | by eLife | News | Comments

Blocking the hormone that raises sugar levels in the blood could increase insulin levels while keeping blood sugar levels down.

TOPICS:

Scorpion Venom Yields Clues for Developing Better Pharmaceuticals

April 19, 2016 8:45 am | by UC Davis | News | Comments

The controlled release of calcium is a key step in many cellular processes.

TOPICS:

Multi-Blockbuster Drugs Will Drive Immuno-Oncology Market to $34B

April 19, 2016 8:40 am | by Dan Roberts, Ph.D., Senior Oncology & Hematology Analyst, GlobalData | Articles | Comments

Immuno-oncology products have demonstrated comparable respective efficacy and safety profiles.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading